23-10-30 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
23-08-03 GSK Nigeria calls an end to its business, to return cash RE
23-08-03 Glaxo Smithkline Consumer Nigeria To Cease Operations RE
23-08-03 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
23-04-28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
23-01-27 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
23-01-27 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
22-10-28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
22-07-29 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
22-04-28 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
22-01-31 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2021 CI
21-10-25 GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
21-07-29 Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Manager TitleAgeSince
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 2011-07-31
General Counsel - 2017-01-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 12.81M
+2.09%+4.41%+47.35%+163.20% 1,068B
+2.51%+6.88%+58.02%+53.12% 641B
+2.89%+1.39%+35.02%+72.60% 454B
+1.60%+8.30%+38.72%+34.19% 351B
+1.23%+2.76%+38.20%+42.94% 299B
+0.60%+2.37%+18.52%+15.64% 266B
+1.94%+1.42%-27.15%-37.80% 220B
+3.97%+3.32%+22.73%+59.40% 203B
+2.34%-2.02%+12.32%+70.59% 162B
Average +1.72%+2.76%+27.08%+52.65% 407.04B
Weighted average by Cap. +1.88%+2.85%+36.64%+77.92%
Logo GlaxoSmithKline Consumer Nigeria Plc
GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows: - sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products; - sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.
Employees
51
  1. Stock Market
  2. Stocks
  3. GLAXOSMITH Stock